Genotype-Guided Oral P2Y12 Inhibitor Therapy Reduces Cumulative Ischemic Events Following Percutaneous Coronary Intervention - A Prespecified Secondary Analysis of the TAILOR-PCI Randomised Trial
26 August 2022 (11:45 - 12:00)
Organised by:
Slides
About the speaker
Mayo Clinic Hospital-Rochester, Rochester (United States of America)
3 More presentations in this session
Professor F. Zannad (Vandoeuvre-Les-Nancy, FR)
Doctor S. Koudstaal (Gouda, NL)
Professor D. Bhatt (New York City, US)
Access the full session
The Event
ESC Congress 2022
26 August 2022
11:45 CET
